Publication | Closed Access
β-Catenin and AKT are promising targets for combination therapy in acute myeloid leukemia
26
Citations
32
References
2013
Year
Hematological MalignancyTumor BiologyOncologyMedicineAcute Myeloid LeukemiaCombination TherapyPharmacologyRadiation OncologyNovel TherapyCancer ResearchMyeloid Neoplasia
| Year | Citations | |
|---|---|---|
Page 1
Page 1